{"id":"NCT01370590","sponsor":"Organon and Co","briefTitle":"A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)","officialTitle":"A Randomized, Double-Blind, Active-Controlled, Multicenter, Crossover Study to Evaluate the Efficacy and Safety of Ezetimibe/Atorvastatin 10 mg/20 mg Fixed-Dose Combination Tablet Compared to Co-administration of Marketed Ezetimibe 10 mg and Atorvastatin 20 mg in Patients With Primary Hypercholesterolemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2012-04","completion":"2012-04","firstPosted":"2011-06-10","resultsPosted":"2013-08-05","lastUpdate":"2022-02-09"},"enrollment":406,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Atorvastatin","otherNames":["Lipitor®"]},{"type":"DRUG","name":"Ezetimibe","otherNames":["Zetia®"]},{"type":"DRUG","name":"Ezetimibe/atorvastatin","otherNames":["Liptruzet®","MK-0653C"]},{"type":"DRUG","name":"Placebo to atorvastatin","otherNames":[]},{"type":"DRUG","name":"Placebo to ezetimibe","otherNames":[]},{"type":"DRUG","name":"Placebo to ezetimibe/atorvastatin","otherNames":[]}],"arms":[{"label":"Ezetimibe and atorvastatin","type":"ACTIVE_COMPARATOR"},{"label":"Ezetimibe/atorvastatin combination","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether ezetimibe/atorvastatin 10 mg/20 mg combination tablet is equivalent to the coadministration of ezetimibe 10 mg and atorvastatin 20 mg in lowering low-density-lipoprotein-cholesterol (LDL-C) after 6 weeks of treatment.","primaryOutcome":{"measure":"Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) After 6 Weeks of Treatment","timeFrame":"Baseline and Week 6","effectByArm":[{"arm":"Ezetimibe/Atorva Fixed Dose Combination","deltaMin":-54,"sd":null},{"arm":"Co-Administration Ezetimibe and Atorvastin","deltaMin":-53.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":8},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["25431239"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":383},"commonTop":[]}}